RAC2 G12V MUTANT FOR USE IN ABLATING HEMATOPOIESIS AND IN THE TREATMENT OF HEMATOPOIETIC MALIGNANCIES
Publication
EP4414002A2
Kind: A2
Mar 18, 2026
Applicants
Institut National de la Santé et de la Recherche Médicale, Fondation Imagine, APHP (Assistance Publique - Hôpitaux de Paris), Université Paris Cité, Université Toulouse III - Paul Sabatier
Inventors
LAGRESLE-PEYROU, Chantal, OLICHON, Aurélien, SADEK-ROCK, Hanem, ANDRE, Isabelle, CAVAZZANA, Marina
IPC Classifications
A61K 38/17 20060101AFI20240911BHEP
A61K 31/713 20060101ALI20240911BHEP
A61P 35/02 20060101ALI20240911BHEP
C07K 14/00 20060101ALI20240911BHEP
A61K 48/00 20060101ALI20240911BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR